Vitaliy Khutoryanskiy
Vitaliy Khutoryanskiy is a renowned pharmaceutical scientist and academic, known for his significant contributions to the field of pharmaceutical sciences. He is currently a Professor of Pharmaceutics at the University of Reading, where he leads a research group focused on the development of advanced drug delivery systems and biomaterials.
Early Life and Education[edit | edit source]
Vitaliy Khutoryanskiy was born and raised in Ukraine. He completed his undergraduate studies in Chemistry at the Taras Shevchenko National University of Kyiv. He then pursued his PhD in Polymer Chemistry from the same university.
Career[edit | edit source]
After completing his PhD, Khutoryanskiy moved to the United Kingdom where he joined the University of Reading as a Postdoctoral Researcher. He later became a Lecturer in the School of Pharmacy, and was subsequently promoted to Professor of Pharmaceutics.
His research interests include the development of mucoadhesive materials, hydrogels, and nanoparticles for drug delivery. He has published numerous peer-reviewed articles in these areas and has received several awards for his work.
Research Contributions[edit | edit source]
Khutoryanskiy's research has significantly advanced the field of drug delivery. His work on mucoadhesive materials has led to the development of new strategies for delivering drugs to mucosal surfaces. His research on hydrogels has contributed to the understanding of their properties and potential applications in drug delivery. He has also made significant contributions to the field of nanoparticle drug delivery, developing new methods for the preparation and characterization of nanoparticles.
Awards and Honors[edit | edit source]
Over the course of his career, Khutoryanskiy has received several awards and honors for his contributions to the field of pharmaceutical sciences. These include the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Grant and the American Association of Pharmaceutical Scientists (AAPS) New Investigator Grant in Pharmaceutics and Drug Delivery.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
